Boustead Singapore Limited (SGX:F9D)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	752	531	458	394	473	489
Market Cap Growth	15.83%	15.83%	16.36%	-16.65%	-3.33%	67.25%
Enterprise Value	461	272	236	273	304	498
Last Close Price	1.53	1.04	0.88	0.72	0.81	0.78
PE Ratio	7.82	5.59	7.14	8.69	15.46	4.32
Forward PE	-	19.23	19.23	19.23	19.23	19.23
PS Ratio	1.43	1.01	0.60	0.70	0.75	0.71
PB Ratio	1.26	0.89	0.87	0.69	0.75	0.73
P/TBV Ratio	1.30	0.92	0.91	0.88	1.09	1.10
P/FCF Ratio	10.78	7.61	5.01	5.37	9.20	8.23
P/OCF Ratio	9.56	6.75	4.75	5.16	8.60	7.83
PEG Ratio	-	2.36	2.36	2.36	2.36	2.36
EV/Sales Ratio	0.87	0.52	0.31	0.49	0.48	0.73
EV/EBITDA Ratio	5.23	2.65	2.45	5.21	7.82	6.74
EV/EBIT Ratio	5.82	2.77	2.64	5.73	9.16	7.71
EV/FCF Ratio	6.60	3.91	2.58	3.72	5.92	8.38
Debt / Equity Ratio	0.07	0.07	0.07	0.09	0.11	0.10
Debt / EBITDA Ratio	0.38	0.38	0.38	0.88	1.55	0.80
Debt / FCF Ratio	0.58	0.58	0.42	0.69	1.34	1.09
Asset Turnover	0.48	0.48	0.68	0.51	0.56	0.63
Inventory Turnover	32.86	32.86	73.00	105.48	94.66	27.51
Quick Ratio	1.24	1.24	1.30	1.33	2.08	1.93
Current Ratio	1.40	1.40	1.41	1.42	2.21	2.05
Return on Equity (ROE)	17.79%	17.79%	13.12%	9.34%	5.97%	30.77%
Return on Assets (ROA)	5.58%	5.58%	4.98%	2.68%	1.85%	3.69%
Return on Capital (ROIC)	10.22%	10.22%	9.43%	4.50%	2.90%	5.60%
Return on Capital Employed (ROCE)	14.50%	14.50%	13.90%	7.00%	4.40%	8.30%
Earnings Yield	12.64%	17.90%	14.00%	11.51%	6.47%	23.13%
FCF Yield	9.27%	13.14%	19.97%	18.64%	10.87%	12.15%
Dividend Yield	3.50%	5.29%	6.28%	5.57%	4.91%	5.14%
Payout Ratio	38.33%	14.46%	29.75%	42.48%	71.19%	12.91%
Buyback Yield / Dilution	-1.73%	-1.73%	0.57%	0.63%	0.57%	0.88%
Total Shareholder Return	1.78%	3.56%	6.86%	6.20%	5.48%	6.02%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.